News

Deal Announcements

Anaphore Accepts Series A Venture Capital Funding

Friday, January 9, 2009 5:36:00 AM PDT | VentureDeal Staff
San Diego, California  --  Biotechnology company Anaphore said that it has secured $25 million in its series A round of venture capital investment.

Anaphore is developing treatments for immune-based diseases via protein therapeutic technologies.

The investment round was led by 5AM Ventures, and included Versant Ventures and Apposite Capital. The company did not disclose how it would use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1